The Stent for Life Initiative is supported by various industry partners who believe in our mission. They have no influence on the scientific content of the Initiative.
Servier is an international pharmaceutical company governed by a non-profit foundation, with its headquarters in France (Suresnes). With a strong international presence in 148 countries and a turnover of 4 billion euros in 2016, Servier employs 21,000 people worldwide. Entirely independent, the Group reinvests 25% of its turnover (excluding generic drugs) in research and development and uses all its profits for development. Corporate growth is driven by Servier’s constant search for innovation in five areas of excellence: cardiovascular, immune-inflammatory and neuropsychiatric disease, oncology and diabetes, as well as by its activities in high-quality generic drugs.
AstraZeneca is an Anglo–Swedish multinational pharmaceutical and biopharmaceutical company. AstraZeneca has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. The company was founded in 1999 through the merger of the Swedish Astra AB and the English Zeneca Group (itself formed by the demerger of the pharmaceutical operations of Imperial Chemical Industries in 1993). In 2015, it was the eighth-largest drug company in the world based on sales revenue.
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 100,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.
Healthcare is changing. That’s why, as a global leader in medical technology, services, and solutions, we’re collaborating with others to take on the industry’s greatest challenges. From collaboration to case studies, Medtronic is changing how the world delivers patient care. Today more than ever — our value as a company and our business performance are connected to our positive social impact.
We improve the quality of life, ensuring human right to get effective high-quality medicines. We strive to be the leader of the national pharmaceutical industry and a competitive player in the international markets.
We build relationships with each employee based on mutual responsibility and trust. We unlock the potential of each employee, ensuring Farmak’s leadership and sustainable development. We understand innovations as constant improvements. The purpose of our focus on innovation is to reach company’s main strategic goals rather than to get short-term benefits. We use modern scientific achievements in order to develop and produce medicines. High quality standards foster customers’ loyalty to our products.
Crown Agents is an international company with over 185 years of experience in implementing projects aimed at achieving sustainable economic and social prosperity. We work side by side with governments, state-owned, non-governmental and international organizations in nearly 100 countries. We provide consultancy and training in health systems strengthening, trade and growth, public financial management and governance. We have permanent offices in 22 countries and presence in another 18 through our project offices and representatives.
For 20 years, Crown Agents is a reliable partner of Ukraine assisting in implementation of projects in the areas of procurement, financial management and economic development. Over the last few years, our efforts have been focused on harmonization of public procurement system in Ukraine with EU standards and the implementation of procurement for the Ministry of Health of Ukraine.
Takeda is a patient-focused, innovation-driven global pharmaceutical company that builds on a distinguished 235-year history, aspiring to bring better health and a brighter future for people worldwide.
The network of Takeda spans over 70 countries and regions worldwide, in Japan, the United States, Europe, Latin America, Africa, the Middle East, and the Asia Pacific Region. Takeda’s pharmaceutical products are marketed in around 100 countries worldwide, including partnerships (marketing alliance partners).
At Pfizer, we believe that innovation comes from working in partnership with others. We are innovating to bring therapies to patients that allow them to live better and longer lives and vaccines to prevent them from becoming sick in the first place.
We are proud to be part of an industry that has helped treat, cure and eradicate life-threatening diseases. We play an active role across the Australian healthcare spectrum working with patient organisations and government for the benefit of each patient.
Since 1956, our people have worked together with our partners for the sole purpose of ensuring that Australians can access new and innovative medicines to extend and improve life. We are proud of our history and look forward with enthusiasm to the future.
Aspen is committed to providing high quality medicines at prices that are competitive and represent fair value to our customers and patients. One of our key focus areas for Europe is the thrombosis therapeutic category, particularly revitalising important anti-thrombotic medicines that meet society’s healthcare needs. The prevention and management of venous thromboembolism is currently a major unmet need in Europe.
With a portfolio of valued anti-thrombotic medicines and focused expertise in the thrombotic therapeutic category, Aspen Europe is set to become a leader in this field.
We create breakthrough products – in diagnostics, medical devices, nutrition and branded generic pharmaceuticals – that help you, your family and your community lead healthier lives, full of unlimited possibilities. Today, 94,000 of us are working to make a lasting impact on health in the more than 150 countries we serve.
For more than 125 years, we’ve put science and innovation to work – to create more possibilities for more people through the power of health. We adapt and respond quickly to changes in the world around us to deliver better solutions to help people live their best lives.